๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The use of zolpidem in the treatment of progressive supranuclear palsy

โœ Scribed by C. Cotter; T. Armytage; D. Crimmins

Book ID
116675167
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
58 KB
Volume
17
Category
Article
ISSN
0967-5868

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Physostigmine treatment of progressive s
Physostigmine treatment of progressive supranuclear palsy
โœ Irene Litvan; Claudia Gomez Med; John R. Atack; Marjorie Gillespie; Anne M. Kask ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 457 KB ๐Ÿ‘ 2 views
Diagnostic accuracy of progressive supra
Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank
โœ Keith A. Josephs; Dennis W. Dickson ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 81 KB

## Abstract Diagnostic accuracy has been addressed previously for Parkinson's disease in a brain bank collection, but accuracy of progressive supranuclear palsy (PSP) has not been addressed in a similar setting. Clinical and genetic features of pathologically confirmed cases of PSP were compared wi

Treatment of progressive supranuclear pa
Treatment of progressive supranuclear palsy and corticobasal degeneration
โœ Anthony E. Lang ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 230 KB

Success in treating patients with progressive supranuclear palsy and corticobasal degeneration remains exceedingly low. This finding probably relates to the widespread distribution of the pathological changes that account for the varied and complex spectrum of clinical manifestations. Dopaminergic d

Epidemiology of progressive supranuclear
Epidemiology of progressive supranuclear palsy
โœ N. Vanacore; V. Bonifati; C. Colosimo; G. Fabbrini; G. De Michele; R. Marconi; D ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Springer Milan ๐ŸŒ English โš– 38 KB